Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1Leukemia 1Congenital Abnormalities 1

Interventions

Cytarabine 9Etoposide 4Daunorubicin 4Idarubicin 3Mitoxantrone 2Gemtuzumab 2Clofarabine 2Asparaginase 2tipifarnib 1temsirolimus 1palmitoyl-L-asparaginase 1midostaurin 1etoposide phosphate 1eltrombopag 1dexamethasone acetate 1alvocidib 1aldesleukin 1Whole-Body Irradiation 1Thioguanine 1Proto-Oncogene Proteins c-kit 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1Observation 1Lenalidomide 1Imatinib Mesylate 1Gene Expression Profiling 1Flow Cytometry 1Filgrastim 1Busulfan 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leukemia, Eosinophilic, Acute × Proto-Oncogene Proteins c-kit × Clear all
NCT00509093 2020-03-17

Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy

Case Comprehensive Cancer Center

Phase 2 Completed
32 enrolled 14 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡